Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary

Guardion Health Sciences

13/05/2024 23:35

* Guardion Health Sciences Inc  GHSI.OQ  reported a
quarterly
adjusted loss of $3.71​​ per share for the quarter ended in
March, lower than the same quarter last year, when the company
reported EPS of 42 cents.  The lone analyst forecast for the
quarter was for a loss of 88 cents per share. 
    * Revenue fell 5.8% to $3.00 million from a year ago;
analysts
expected $3.12 million. 
    * Guardion Health Sciences Inc's reported EPS for the
quarter was
a loss of $3.71​.
    * The company reported a quarterly loss of $4.75 million.
    * Guardion Health Sciences Inc shares had fallen by 8.9%
this
quarter and gained 54.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is  "hold."

Wall Street's median 12-month price target for Guardion Health
Sciences Inc is $40.00 
This summary was machine generated from LSEG data May 13 at
10:35 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.88          -3.71          Missed
 Dec. 31 2023      -0.73          0.65           Beat
 Sep. 30 2023      -0.87          0.29           Beat
 Jun. 30 2023      -0.93          -0.93          Met